RICE HALL JAMES & ASSOCIATES, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$956,442
-27.0%
363,666
-2.0%
0.06%
-17.6%
Q2 2023$1,309,750
+15.3%
371,034
+1.0%
0.07%
+13.8%
Q1 2023$1,135,566
-29.9%
367,497
-4.1%
0.06%
-30.1%
Q4 2022$1,621,012
+76.6%
383,218
-1.1%
0.09%
+75.5%
Q3 2022$918,000
-36.3%
387,539
-23.4%
0.05%
-24.3%
Q2 2022$1,442,000
-2.0%
506,066
-1.0%
0.07%
+18.6%
Q1 2022$1,472,000
-1.4%
511,233
+4.1%
0.06%
+11.3%
Q4 2021$1,493,000
-61.0%
491,282
-10.1%
0.05%
-62.7%
Q3 2021$3,830,000
-23.5%
546,308
+0.1%
0.14%
-20.2%
Q2 2021$5,009,000
-14.9%
545,616
-9.9%
0.18%
-7.3%
Q1 2021$5,888,000
-5.1%
605,792
+0.1%
0.19%
-11.9%
Q4 2020$6,207,000
+5.9%
604,937
+4.1%
0.22%
-7.6%
Q3 2020$5,862,000
+23.4%
580,995
+27.5%
0.24%
+15.7%
Q2 2020$4,752,000
+20.7%
455,567
-2.3%
0.20%
-7.3%
Q1 2020$3,937,000
-11.9%
466,482
-8.7%
0.22%
+45.7%
Q4 2019$4,470,000
-25.1%
510,856
-7.8%
0.15%
-29.1%
Q3 2019$5,964,000
-16.0%
553,992
-0.9%
0.21%
-9.7%
Q2 2019$7,103,000
-68.3%
558,889
-3.4%
0.24%
-67.4%
Q1 2019$22,442,000
+136.5%
578,551
+24.1%
0.72%
+109.0%
Q4 2018$9,489,000
-13.4%
466,310
+95.1%
0.35%
-11.7%
Q3 2018$10,958,000
+6.0%
238,999
+36.8%
0.39%
+4.3%
Q2 2018$10,337,000
-9.6%
174,757
+4.0%
0.38%
-15.7%
Q1 2018$11,430,000
+8.8%
167,964
+58.1%
0.45%
+8.0%
Q4 2017$10,505,000
+276.3%
106,272
+355.7%
0.41%
+233.1%
Q3 2017$2,792,000
+32.6%
23,319
-3.2%
0.12%
+34.8%
Q2 2017$2,106,00024,0990.09%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders